Pharmaceutical Services

 

AmoyDx (North America) Laboratory partners with pharmaceutical companies to drive innovation in oncology drug development. We specialize in cutting-edge molecular and cellular testing methodologies, including Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), and Fluorescence In Situ Hybridization (FISH). Our pharmaceutical services include:​

 

Clinical Trial Assay (CTA) service: Providing reliable and robust molecular diagnostic assay to support clinical trials and drug efficacy studies. High-quality assay design and validation to meet the rigorous demands of clinical trials, ensuring reliable and actionable results.

 

Companion Diagnostics (CDx) Co-Development: Collaborating with pharma partners to develop and validate companion diagnostic tools, seamlessly integrating diagnostic solutions with therapeutic strategies, we co-develop tools that guide treatment decisions and enhance patient outcomes.

​

​